TipRanks
Medexus Pharmaceuticals Inc (DE:P731)
FRANKFURT:P731
Germany Market
P731
Medexus Pharmaceuticals Inc
RESEARCH TOOLSreports

Medexus Pharmaceuticals Inc (P731) Income Statement

2 Followers

Medexus Pharmaceuticals Inc Income Statement

Last quarter (Q1 2027), Medexus Pharmaceuticals Inc's total revenue was C$28.59M, an increase of 16.13% from the same quarter last year. In Q1, Medexus Pharmaceuticals Inc's net income was C$547.66K. See Medexus Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 24Mar 23Mar 22Mar 21
Total Revenue
$ 99.33M$ 108.33M$ 108.10M$ 76.70M$ 79.66M
Gross Profit
$ 54.41M$ 56.58M$ 60.04M$ 37.93M$ 42.01M
Operating Expenses
$ 48.58M$ 48.36M$ 52.42M$ 50.30M$ 43.38M
Depreciation and Amortization
$ 9.73M$ 7.18M$ 6.08M$ 6.14M$ 7.90M
EBITDA
$ 12.66M$ 16.81M$ 14.65M$ 14.55M$ -23.61M
Operating Income
$ 5.83M$ 8.22M$ 7.61M$ -12.38M$ -1.38M
Other Income/Expenses
$ -8.11M$ -6.78M$ -12.65M$ 8.56M$ -30.13M
Pretax Income
$ -2.27M$ 1.44M$ -5.04M$ -3.82M$ -31.50M
Net Income
$ -2.39M$ 2.25M$ 1.22M$ -2.88M$ -28.26M
Per Share Metrics
Basic EPS
$ -0.07$ 0.09$ 0.08$ -0.19$ -1.86
Diluted EPS
$ -0.07$ 0.08$ 0.08$ -0.19$ -1.86
Weighted Average Shares Outstanding
 32.32M 25.82M 19.98M 19.45M 15.20M
Weighted Average Shares Outstanding (Diluted)
 32.32M 26.51M 20.52M 19.86M 15.20M

Medexus Pharmaceuticals Inc Earnings and Revenue History